Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVT-501 (tapinarof) in pediatric atopic dermatitis
NCT03394677Phase 2Completed
- Sponsor
- Dermavant Sciences
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tapinarof in atopic dermatitis (AD), sponsored by Dermavant Sciences. Started Jan 2018; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03394677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394677.